In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
New research from McGill University suggests that nerve injuries don’t just hurt the affected area, they can trigger hidden ...
Doctronic reports that AI telehealth visits reveal Americans primarily seek pain management and chronic disease prescriptions ...
Many surgeons recommend giving up smoking, alcohol, or drugs before surgery, but researchers have found this may also ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
News-Medical.Net on MSN
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
Patients in pain may not associate psychologists with an avenue for help, yet their expertise can be a part of an innovative ...
This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...
Migraine is often minimized as simple pain, but we must treat it as a complex neurological cascade involving cortical ...
Adults with chronic pain who participated in New York State's (NYS) Medical Cannabis Program were significantly less likely ...
New study shows how digital self-management resources for people living with chronic musculoskeletal disorders can be made more accessible and patient-centred.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback